Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022–2023

Authors

Ana Goios (ORCID: https://orcid.org/0000-0002-3297-8420)
Lucy Carty (ORCID: https://orcid.org/0000-0003-2849-3145)
Kathryn L. Evans (ORCID: https://orcid.org/0000-0002-7884-5877)
Rachael A Evans (ORCID: https://orcid.org/0000-0002-1667-868X)
Sabada Dube (ORCID: https://orcid.org/0000-0001-8631-8244)
Nahila Justo (ORCID: https://orcid.org/0000-0001-7981-7299)
Sudhir Venkatesan (ORCID: https://orcid.org/0000-0002-2093-5781)
Lance Turtle
Sylvia Taylor
Wilhelmine Meeraus
Jennifer K. Quint
Yi Lu

Institutions

University of Liverpool (GB)
Thermo Fisher Scientific (Sweden) (SE)
AstraZeneca (France) (FR)
Thermo Fisher Scientific (United Kingdom) (GB)
AstraZeneca (Switzerland) (CH)
Thermo Fisher Scientific (United States) (US)
NIHR Leicester Biomedical Research Centre (GB)
Imperial College London (GB)
UCLouvain (BE)

Publication Details

Journal: Infectious Diseases and Therapy
Published: 2026-03-27
DOI: https://doi.org/10.1007/s40121-026-01332-5
Primary Topic: Influenza Virus Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022–2023

Ana Goios, Lucy Carty, Kathryn L. Evans, Rachael A Evans et al.

Mar 27, 2026

Infectious Diseases and Therapy

Influenza Virus Research Studies

article

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022–2023

Ana Goios, Lucy Carty, Kathryn L. Evans, Rachael A Evans, Sabada Dube, Nahila Justo, Sudhir Venkatesan, Lance Turtle, Sylvia Taylor, Wilhelmine Meeraus, Jennifer K. Quint, Yi Lu

March 27, 2026article en

Abstract

No abstract available for this paper.

Infectious Diseases and Therapy

University of Liverpool (GB), Thermo Fisher Scientific (Sweden) (SE), AstraZeneca (France) (FR), Thermo Fisher Scientific (United Kingdom) (GB), AstraZeneca (Switzerland) (CH), Thermo Fisher Scientific (United States) (US), NIHR Leicester Biomedical Research Centre (GB), Imperial College London (GB), UCLouvain (BE)

Openalex Percentile: Top 6%

Influenza Virus Research Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022–2023 — Ana Goios, Lucy Carty, et al. · Infectious Diseases and Therapy (2026) | TGRS Research Map | TGRS